FDA Investigator Fannie M Harrell
Fannie M Harrell has inspections in 1 countries as of 04 Oct 2023. Fannie M Harrell has collaborated with a combinined 3445 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
249
Last Inspection Date:
04 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron L Dunbar,
Aimee J Edwin,
Alecia L Marson,
Alfred P Pistorio,
Alison A Nicoli,
Amir Alavi,
Amos,
Amy L Mcintyre,
Ana M Placencia,
Anthony J Ladner,
Anthony L Nicoli,
April L Young,
Artem Melnik,
Aswin T Subketkaew,
Baask,
Benedict,
Billi Jom Johnson,
Boun M Xiong,
Bradley A Servais,
Brian E Thompson,
Brian L Szcyubialka,
Brianna R Scott,
Bunce,
Carolyn A Warren,
Catherine M Vanderhoef,
Charles R Cote, RIC,
Christina A Castineyra,
Christine M Erickson,
Como,
Courtney R Ingalsbe,
Courtney R Tiegs,
Dacia E Quick,
Dale A Nyberg,
Darlene L Krieger,
Darren D Holaday,
David B Wieneke,
Debra D Devlieger,
Demetria L Lueneburg,
Denise L Burosh,
Denise M Digiulio,
Diane T Reindl,
Dianna C Sonnenburg,
Douglas J Snyder,
Douglas W Atkins,
Duc Minh H Nguyen,
Edward A Fabiano,
Edward M James,
Elizabeth P Mayer,
Ellen C Weisensel,
Emily E Harlow,
Emily E Markgraf,
English,
Eric A Breselow,
Fallon J Ryan,
Frank S Sedzielarz,
Garrett W Steiner,
Gina M Scholze,
Grant M Ruis,
Gregory A Berg,
Gregory A Ryberg,
Gregory S Larson,
Gregory W Smith,
Heather Akleimola Hulbert,
Heather Akleimola Hurbert,
Heidi J Debeck,
Howard A Burmester,
Hustedtj,
Ivan E Reyes,
Jaclyn N Munsch,
Jake T Lane,
James K Ireland,
James R Evans,
Jamie R Thompson,
Jane E Nelson,
Janis R Armedoriz,
Jasjeet K Sekhon,
Jean M Bosenbecker,
Jeffery A Hangartner,
Jeffry A Bernhardt,
Jennifer Alongie Vollom,
Jennifer Guttuso,
Jennifer R Mathern,
Jennifer S Ness,
Jeremy L Tri,
Jesse P Romenesko,
Jessica M Novak,
Joel D Hustedt,
John E Emmert,
Jon C Polzine,
Jonathan G Swoboda,
Jonathan L Blonk,
Jonell R O'neil,
Joseph J Golden,
Julie Woodberry,
Kailas Nagaraj,
Karen M Gasperic,
Karen M Labounty,
Karla J Youngberg,
Katherine A Clarke Girolamo,
Kathryn M Mogen,
Kazar,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kevin P Regan,
Kia L Copeland,
Kibily D Dembele,
Kimberly Lewandowski Walker,
Kimberly W Destromp,
Krista K Petersen,
Kristine J Mantaring,
Kristy E Zuroski,
Kristy Zivski,
Kyle J Mccracken,
Larae M Koopman,
Lauren E Merz,
Lauren E Sanger,
Leon R Stratman,
Leonardm,
Liliya V Bubiy,
Linda V Weyer,
Lisa M Lopez,
Lisa M Thursam,
M Edith Snyder,
Mada A Tautges,
Madeline T Campbell,
Margaret L Bolte,
Margaret M Lubbers Solberg,
Maria E Treadwell,
Marie A Fadden,
Maril A Fadden,
Marissa S Steinhagen,
Mary Ann Ruff,
Mary M Finn,
Mary R Chestolowski,
Melanie C Voges,
Melissa D Kalik,
Melissa I Michurski,
Michael E Cimaglio,
Michele L Forster, PhD,
Miles D Foster,
Mohammed H Adam,
Monica E Murie,
Nicole C Shokatz,
Paola E Lathrop,
Patricia A Holmstrom,
Patrick J Campbell,
Peter T Erlandson,
Rebecca L Caulfield,
Rebecca L Keller,
Rebecca L Mullikin,
Rhonda L Mecl,
Richard Jay Tucker, RS,
Robert H Claflin,
Robert J Waldorf,
Ronald R Ruff,
Ross J Grigsby,
Rostislav Servetnyk,
Sana A Elassar,
Sandra A Hughes,
Sandra Sejdinovic,
Sarah A Palmer,
Scott A Golladay,
Scott B Laufenberg,
Scott L Schenian,
Scott T Panagiotis,
Seth A Abbott,
Sharon K Thoma, PharmD,
Sharon L Matson,
Sharon M Harold,
Shaun M Olson,
Soyinka S Eneng,
State Agency,
Steven A Skaar,
Susan M Miller,
Suzanne M Crotty,
Tara C Singh,
Tara M Carolfi,
Tara M Humfeld,
Terrance L Scheiber,
Theresa C Klaman,
Thomas S Donaldson,
Tony T Yang,
Traci C Kelm,
Tracy A Solseng,
Troy A Brenny,
Victoria A Murray,
Victoria L Palmer,
Wayne W Grundstrom,
Wendy L Trefethren Grang,
William E Keer,
William G Craig,
William P Fournier,
Yiyue Zhang (nmi), PhD,
Zachary P Wachlarowicz
Fannie M Harrell's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2001 | EIR | Padagis US LLC - EIR, 2001-01-17 |
| January, 2001 | FDA 483 | Padagis US LLC - Form 483, 2001-01-17 |
| December, 2000 | EIR | Hawkins, Inc. - EIR, 2000-12-12 |
| October, 2000 | FDA 483 | Apex International Mfg LLC - Form 483, 2000-10-11 |
| March, 2000 | EIR | DIVERSIFIED MANUFACTURING CORP - EIR, 2000-03-08 |
| April, 2005 | EIR | TMV Feed & Supply LLP - EIR, 2005-04-12 |
| January, 2001 | FDA 483 Response | Padagis US LLC - Form 483R, 2001-03-02 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more